Literature DB >> 18177585

Direct renin inhibitors: where will they fit in for antihypertensive treatment?

Matthew R Weir.   

Abstract

Entities:  

Year:  2007        PMID： 18177585     DOI： 10.1007/s11906-007-0071-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  8 in total

1.  Renin inhibition: the next step in suppression of the renin-angiotensin system?

Authors:  Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 5.369

2.  Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.

Authors:  Suzanne Oparil; Steven A Yarows; Samir Patel; Hui Fang; Jack Zhang; Andrew Satlin
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

3.  Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.

Authors:  J L Pool; R M Guthrie; T W Littlejohn; P Raskin; A M Shephard; M A Weber; M R Weir; T W Wilson; J Wright; K B Kassler-Taub; R A Reeves
Journal:  Am J Hypertens       Date:  1998-04       Impact factor: 2.689

4.  Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.

Authors:  Matthew R Weir; Christopher Bush; David R Anderson; Jack Zhang; Deborah Keefe; Andrew Satlin
Journal:  J Am Soc Hypertens       Date:  2007 Jul-Aug

5.  Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

Authors:  Eoin O'Brien; John Barton; Juerg Nussberger; David Mulcahy; Chris Jensen; Patrick Dicker; Alice Stanton
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

6.  Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.

Authors:  Michel Azizi; Joël Ménard; Alvine Bissery; Than-Tam Guyenne; Alessandra Bura-Rivière; Sujata Vaidyanathan; Riccardo P Camisasca
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

7.  Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness.

Authors:  Jean E Sealey; John H Laragh
Journal:  Am J Hypertens       Date:  2007-05       Impact factor: 2.689

Review 8.  Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far.

Authors:  Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.